| Risk of investing in healthcare companies:Certain of the companies in which the Fund may invest may allocate greater than usual financial resources to research and product development. The securities of such companies may experience above-average price movements associated with the perceived prospects of success of the research and development programmes. In addition, companies in which the Fund may invest may be adversely affected by lack of commercial acceptance of a new product or process or by technological change and obsolescence. Equities risk:The value of, and income derived from, equity securities held may fall as well as rise and the Fund may not recoup the original amount invested in such securities. The prices of and the income generated by equity securities may decline in response to certain events, including the activities and results of the issuer, general economic and market conditions, regional or global economic instability and currency and interest rate fluctuations. Risk with international investing:Since the Fund invests on an international basis, the value of the assets of the Fund may be affected by uncertainties of the underlying countries such as political, economic or other developments in the law or regulations of the countries in which the Fund may invest. Besides, as the Fund invests in securities denominated in different currencies other than the base currency of the Fund; changes in foreign currency exchange rates will affect the value of Shares held in the Fund. Risk of investing in developing markets:The Fund may invest in emerging markets which involve certain risks such as higher price volatility, less publicly-available information, liquidity and regulatory risk. Investment risk:There can be no assurance that the Fund will achieve its investment objective. There is no guarantee of the repayment of principal. The instruments invested by the Fund may fall in value. |